TXNDC5 and glioblastoma: Our findings showed that LGG (Figure 5A) and all grade patients (Figure 5C) carrying IDH mutation exhibited elevated TXNDC5 expression compared to patients carrying WT IDH whereas there was no difference between these two groups in GBM (Figure 5B).